Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Goodwill & Intangibles (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Goodwill & Intangibles for 9 consecutive years, with $48.7 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Goodwill & Intangibles fell 16.67% year-over-year to $48.7 million, compared with a TTM value of $48.7 million through Mar 2025, down 16.67%, and an annual FY2024 reading of $51.1 million, down 16.0% over the prior year.
  • Goodwill & Intangibles was $48.7 million for Q1 2025 at Puma Biotechnology, down from $51.1 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $72.1 million in Q1 2021 and bottomed at $48.7 million in Q1 2025.
  • Average Goodwill & Intangibles over 5 years is $61.3 million, with a median of $61.5 million recorded in 2022.
  • The sharpest move saw Goodwill & Intangibles soared 82.74% in 2021, then decreased 16.67% in 2025.
  • Year by year, Goodwill & Intangibles stood at $66.1 million in 2021, then rose by 6.78% to $70.6 million in 2022, then fell by 13.79% to $60.9 million in 2023, then decreased by 16.0% to $51.1 million in 2024, then decreased by 4.76% to $48.7 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for PBYI at $48.7 million in Q1 2025, $51.1 million in Q4 2024, and $53.6 million in Q3 2024.